Science Explorer Back to mapMap
Discussion
Institution · Hospital Arnau de Vilanova

Most cited papers from Hospital Arnau de Vilanova

Hospital Arnau de Vilanova

What are the most cited papers from Hospital Arnau de Vilanova?

The most cited paper from Hospital Arnau de Vilanova is "Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease" (Juan José Soler‐Cataluña, 2005), with 1,977 citations. Next come "HLA-B*5701 Screening for Hypersensitivity to Abacavir" (1,847) and "Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study" (1,160).

Showing 50 of 60 papers. Every paper with more than 194 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease Juan José Soler‐Cataluña · Thorax Open access 29 Jul 2005 1,977
2 HLA-B*5701 Screening for Hypersensitivity to Abacavir Simon Alexander Mallal, Elizabeth Jane Phillips, Giampiero Carosi et al. · New England Journal of Medicine Open access 6 Feb 2008 1,847
3 Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study Federico Soriguer et al. · Diabetologia Open access 10 Oct 2011 1,160
4 The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 George W. Sledge, Masakazu Toi, Patrick Neven et al. · JAMA Oncology Open access 29 Sep 2019 1,016
5 Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data François‐Clément Bidard et al. · The Lancet Oncology 11 Mar 2014 848
6 Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of Hypertension José María Marín, Alvar G.N. Agustí, Isabel Salas Villar et al. · JAMA Open access 22 May 2012 788
7 Noninvasive Ventilation in Severe Hypoxemic Respiratory Failure Miquel Ferrer, Antonio Matias Esquinas, M Echeverria Leon et al. · American Journal of Respiratory and Critical Care Medicine 22 Sep 2003 623
8 Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis Miguel Ángel Martínez‐García, Juan José Soler‐Cataluña, Miguel Perpiñá-Tordera et al. · CHEST Journal Nov 2007 491
9 Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 Emma B. Hodcroft et al. · Nature Open access194 authors 7 Jun 2021 458
10 Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer Enriqueta Felip, Rafael Rosell, J Maestre et al. · Journal of Clinical Oncology Open access 2 Jun 2010 435
11 Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule José Baselga, Xavier Carbonell, Noel-Jaime Castañeda-Soto et al. · Journal of Clinical Oncology Open access 30 Mar 2005 428
12 Continuous Positive Airway Pressure Treatment Reduces Mortality in Patients with Ischemic Stroke and Obstructive Sleep Apnea: A 5-Year Follow-up Study Miguel Ángel Martínez‐García, Juan José Soler‐Cataluña, Laura Ejarque-Martínez et al. · American Journal of Respiratory and Critical Care Medicine 30 Apr 2009 392
13 Association between Obstructive Sleep Apnea and Cancer Incidence in a Large Multicenter Spanish Cohort Francisco Campos‐Rodríguez, Miguel Ángel Martínez‐García, Montserrat Martínez‐Alonso et al. · American Journal of Respiratory and Critical Care Medicine 16 Nov 2012 388
14 Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable Marc Miravitlles, Juan José Soler‐Cataluña, Myriam Calle et al. · Archivos de Bronconeumología 4 May 2017 383
15 Survival of Functionally Anuric Patients on Automated Peritoneal Dialysis Edwina Anne Brown, Simon Davies, Peter A. Rutherford et al. · Journal of the American Society of Nephrology Nov 2003 380
16 Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia Chiara Elena et al. · Blood Open access 6 Jul 2016 367
17 Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials Antoinette Moran et al. · The Lancet Open access 5 Apr 2013 360
18 Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial Carlos Fernández-Martos, Xabier García‐Albéniz, Carles Pericay et al. · Annals of Oncology Open access 9 May 2015 360
19 Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients Rafael Rosell, Kathleen D. Danenberg, Vincente Alberola et al. · Clinical Cancer Research Open access 15 Feb 2004 359
20 Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease Miguel Ángel Martínez‐García, David de la Rosa, Juan José Soler‐Cataluña et al. · American Journal of Respiratory and Critical Care Medicine 8 Feb 2013 358
21 HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial Antonio Llombart‐Cussac, Javier Cortés, Laia Paré et al. · The Lancet Oncology 23 Feb 2017 349
22 The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary Anneke Kramer et al. · Clinical Kidney Journal Open access 11 Jan 2019 345
23 Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease Peter M.A. Calverley, Fernando Sánchez-Toril, Andrew McIvor et al. · American Journal of Respiratory and Critical Care Medicine Open access 26 Apr 2007 326
24 Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial Ian E. Krop et al. · The Lancet Oncology Open access 5 May 2016 300
25 Cardiovascular Mortality in Obstructive Sleep Apnea in the Elderly: Role of Long-Term Continuous Positive Airway Pressure Treatment: A Prospective Observational Study Miguel Ángel Martínez‐García, Francisco Campos‐Rodríguez, Pablo Catalán et al. · American Journal of Respiratory and Critical Care Medicine 15 Sep 2012 299
26 Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes Melissa Ann Wilson, Rory O’Hanlon, Sanjay Kumar Prasad et al. · Journal of Applied Physiology Open access 17 Feb 2011 299
27 Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis François‐Clément Bidard et al. · JNCI Journal of the National Cancer Institute ReviewOpen access 26 Jan 2018 283
28 Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort Borja G. Cosío et al. · CHEST Journal 20 Aug 2015 278
29 Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance Alicia M. Maceira, Juan Cosı́n-Sales, Michael Roughton et al. · Journal of Cardiovascular Magnetic Resonance Open access Oct 2010 276
30 The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper Massimo Cristofanilli et al. · Critical Reviews in Oncology/Hematology Open access 19 Dec 2018 275
31 Consensus Document on the Overlap Phenotype COPD–Asthma in COPD Juan José Soler‐Cataluña et al. · Archivos de Bronconeumología 23 Jul 2012 268
32 Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis Alicia M. Maceira, Sanjay Kumar Prasad, Philip Nigel Hawkins et al. · Journal of Cardiovascular Magnetic Resonance Open access 2008 268
33 Cytogenetic risk stratification in chronic myelomonocytic leukemia Esperanza Such et al. · Haematologica Open access 25 Nov 2010 265
34 Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable Marc Miravitlles, Juan José Soler‐Cataluña, Myriam Calle Rubio et al. · Archivos de Bronconeumología 13 Jun 2012 259
35 Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer Luis G Paz-Ares, Bonne Biesma, David Felix Heigener et al. · Journal of Clinical Oncology Open access 31 Jul 2012 259
36 Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial José Manuel Pérez-García, Marta Vaz Batista, Patricia Cortez et al. · Neuro-Oncology Open access 26 May 2022 251
37 Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma Expresses Follicular T-cell Markers Socorro Marıá Rodríguez-Pinilla, Giovanna Roncador, José Luis Rodríguez‐­Peralto et al. · The American Journal of Surgical Pathology 30 Dec 2008 250
38 Diagnóstico y tratamiento del síndrome de apneas-hipopneas del sueño Patrícia Lloberes, Joaquín Durán‐Cantolla, Miguel Ángel Martínez‐García et al. · Archivos de Bronconeumología Mar 2011 249
39 Health-related quality of life in patients by COPD severity within primary care in Europe Paul Jones, Guy Brusselle, Roberto Walter Dal Negro et al. · Respiratory Medicine Open access 8 Oct 2010 244
40 Documento de consenso sobre el fenotipo mixto EPOC-asma en la EPOC Juan José Soler‐Cataluña et al. · Archivos de Bronconeumología 15 Feb 2012 244
41 Night-time symptoms: a forgotten dimension of COPD Alvar G.N. Agustí, Jan Anders Hedner, José María Marín et al. · European Respiratory Review Open access 31 Aug 2011 243
42 Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study Vı́ctor de Lorenzo, Marisa Martín, Margarita Rufino et al. · American Journal of Kidney Diseases Jun 2004 240
43 Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study Pedro Ruiz et al. · Movement Disorders 28 Apr 2008 234
44 Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer Rodrigo Jover, P Zapater, A Castells et al. · Gut Open access 18 Nov 2005 233
45 Clinical features and survival of lung cancer patients with pleural effusions José Manuel Porcel, Ariadna Gasol, Silvia Bielsa et al. · Respirology 23 Feb 2015 233
46 Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3 M.P. Goetz et al. · Annals of Oncology Open access 8 May 2024 232
47 Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients H. Cortés-Funes et al. · Annals of Oncology Open access 26 Apr 2005 231
48 Risk of Cancer in Cases of Suspected Lynch Syndrome Without Germline Mutation María Rodríguez–Soler et al. · Gastroenterology Open access 24 Jan 2013 227
49 Spanish Guideline for COPD (GesEPOC). Update 2014 Marc Miravitlles, Juan José Soler‐Cataluña, Myriam Calle Rubio et al. · Archivos de Bronconeumología 2014 222
50 Continuous Positive Airway Pressure Treatment in Sleep Apnea Prevents New Vascular Events After Ischemic Stroke Miguel Ángel Martínez‐García, Rafael Galiano-Blancart, Pilar Román-Sánchez et al. · CHEST Journal Oct 2005 217

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.